Calliditas Therapeutics AB (publ)
Calliditas Therapeutics AB (publ)（CALT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
calt · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2025年10月6日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Hold
5 位分析师
共识
评级分布
12 个月目标价
High
$40.00
Consensus
$39.50
-1.3% upside
Low
$39.00
Median: $39.5 · Last Close: $40.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$39.50
-1.3% upside
High Target
$40
0.0%
Low Target
$39
-2.5%
Current Price
$40.00
as of today
Based on analyst price targets, the CALT stock price prediction for the next 12 months ranges from $39 to $40. The consensus CALT price forecast of $39.50 implies -1.3% upside from the current price of $40.00.
短期股价预测
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CALT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-05-31 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2024-05-28 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2024-05-28 | Stifel | Downgrade ↓ | Buy→Hold |
| 2024-05-28 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-05-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Calliditas Therapeutics AB (publ) (CALT) stock. Of the recent 20 rating actions, 0 were upgrades and 4 were downgrades. 5 analysts currently cover CALT.
分析师推荐趋势
CALT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2.3B
↓ 50.8% YoY
Revenue Next Year
$3.3B
↑ 46.7% YoY
EPS This Year
$-2.01
EPS Next Year
$40.08
↓ 2090.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast CALT EPS of $-2.01 for the current fiscal year, based on estimates from 1 analysts. The CALT revenue forecast is $2.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CALT 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CALT 的共识目标价为 $39.50（-1.3% 上行空间），分析师共识为 Hold。
Calliditas Therapeutics AB (publ) 在 NASDAQ 上市，代码 CALT。CALT 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 0% 对应 Hold 共识。
常见问题
CALT 预测 · 8 个问题根据 5 位华尔街分析师，CALT 的 12 个月平均目标价为 $39.50，最高 $40.00、最低 $39.00。若有图表，中位目标价可在上方查看。相对当前价 $40.00，隐含约 -1.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.